SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3kkz'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H4O_A_BEZA1162_0 (PEROXIREDOXIN 5)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	5 / 10	THR A 73 GLY A 100 LEU A 108 PHE A 110 GLY A 103	None	1.44A	1h4oA-3kkzA: undetectable 1h4oB-3kkzA: undetectable	1h4oA-3kkzA: 18.70 1h4oB-3kkzA: 18.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2J2P_F_SC2F1291_1 (FICOLIN-2)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	4 / 6	LEU A 108 SER A 104 ASP A 106 GLU A 135	None SAM A 301 (-3.1A) None None	1.22A	2j2pE-3kkzA: undetectable 2j2pF-3kkzA: undetectable	2j2pE-3kkzA: 20.36 2j2pF-3kkzA: 20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2KQE_A_ADNA1002_1 (APRATAXIN AND PNK-LIKE FACTOR)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	4 / 5	TYR A 249 SER A 152 CYH A 151 TYR A 247	None	1.44A	2kqeA-3kkzA: 0.0	2kqeA-3kkzA: 14.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7K_A_SALA1302_1 (LYSR-TYPE REGULATORY PROTEIN)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	5 / 11	THR A 73 ILE A 101 GLY A 74 PRO A 109 ILE A 53	None	1.36A	2y7kA-3kkzA: undetectable	2y7kA-3kkzA: 24.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KKZ_A_SAMA301_0 (UNCHARACTERIZED PROTEIN Q5LES9)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	12 / 12	ARG A 25 GLN A 26 GLY A 54 GLY A 56 GLN A 60 LEU A 75 PHE A 77 LEU A 78 SER A 104 GLU A 121 ALA A 123 ASN A 126	SAM A 301 (-3.7A) SAM A 301 (-4.4A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-3.4A) None None SAM A 301 ( 4.1A) SAM A 301 (-3.1A) None SAM A 301 ( 3.7A) SAM A 301 (-3.0A)	0.00A	3kkzA-3kkzA: 46.9	3kkzA-3kkzA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KKZ_B_SAMB302_0 (UNCHARACTERIZED PROTEIN Q5LES9)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	12 / 12	ARG A 25 GLN A 26 GLY A 27 GLY A 54 GLY A 56 GLN A 60 PHE A 77 LEU A 78 SER A 104 GLU A 121 ALA A 123 ASN A 126	SAM A 301 (-3.7A) SAM A 301 (-4.4A) SAM A 301 (-4.0A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-3.4A) None SAM A 301 ( 4.1A) SAM A 301 (-3.1A) None SAM A 301 ( 3.7A) SAM A 301 (-3.0A)	0.28A	3kkzB-3kkzA: 43.7	3kkzB-3kkzA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SXJ_A_SAMA258_0 (PUTATIVE METHYLTRANSFERASE)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	11 / 12	ARG A 25 GLN A 26 GLY A 54 GLY A 56 GLN A 60 SER A 104 MET A 105 GLU A 121 ALA A 123 TYR A 125 ASN A 126	SAM A 301 (-3.7A) SAM A 301 (-4.4A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-3.4A) SAM A 301 (-3.1A) SAM A 301 (-4.5A) None SAM A 301 ( 3.7A) None SAM A 301 (-3.0A)	0.29A	3sxjA-3kkzA: 38.4	3sxjA-3kkzA: 61.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SXJ_B_SAMB258_0 (PUTATIVE METHYLTRANSFERASE)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	11 / 12	ARG A 25 GLN A 26 GLY A 54 GLY A 56 GLN A 60 SER A 104 MET A 105 GLU A 121 ALA A 123 TYR A 125 ASN A 126	SAM A 301 (-3.7A) SAM A 301 (-4.4A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-3.4A) SAM A 301 (-3.1A) SAM A 301 (-4.5A) None SAM A 301 ( 3.7A) None SAM A 301 (-3.0A)	0.29A	3sxjB-3kkzA: 38.4	3sxjB-3kkzA: 61.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3T7S_A_SAMA300_0 (PUTATIVE METHYLTRANSFERASE)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	11 / 12	ARG A 25 GLY A 54 GLY A 56 GLN A 60 ASP A 76 PHE A 77 SER A 104 MET A 105 GLU A 121 ALA A 123 ASN A 126	SAM A 301 (-3.7A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-3.4A) SAM A 301 (-2.8A) None SAM A 301 (-3.1A) SAM A 301 (-4.5A) None SAM A 301 ( 3.7A) SAM A 301 (-3.0A)	0.39A	3t7sA-3kkzA: 39.9	3t7sA-3kkzA: 69.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3T7S_A_SAMA300_0 (PUTATIVE METHYLTRANSFERASE)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	5 / 12	GLN A 26 GLY A 54 GLY A 56 ASP A 76 ALA A 123	SAM A 301 (-4.4A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-2.8A) SAM A 301 ( 3.7A)	1.23A	3t7sA-3kkzA: 39.9	3t7sA-3kkzA: 69.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3T7S_B_SAMB300_0 (PUTATIVE METHYLTRANSFERASE)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	12 / 12	ARG A 25 GLN A 26 GLY A 54 GLY A 56 GLN A 60 ASP A 76 PHE A 77 SER A 104 MET A 105 GLU A 121 ALA A 123 ASN A 126	SAM A 301 (-3.7A) SAM A 301 (-4.4A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-3.4A) SAM A 301 (-2.8A) None SAM A 301 (-3.1A) SAM A 301 (-4.5A) None SAM A 301 ( 3.7A) SAM A 301 (-3.0A)	0.33A	3t7sB-3kkzA: 39.3	3t7sB-3kkzA: 69.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3T7S_C_SAMC300_0 (PUTATIVE METHYLTRANSFERASE)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	10 / 12	ARG A 25 GLY A 54 GLY A 56 GLN A 60 SER A 104 MET A 105 GLU A 121 ALA A 123 TYR A 125 ASN A 126	SAM A 301 (-3.7A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-3.4A) SAM A 301 (-3.1A) SAM A 301 (-4.5A) None SAM A 301 ( 3.7A) None SAM A 301 (-3.0A)	0.29A	3t7sC-3kkzA: 40.0	3t7sC-3kkzA: 69.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3T7S_D_SAMD300_0 (PUTATIVE METHYLTRANSFERASE)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	12 / 12	ARG A 25 GLN A 26 GLY A 54 GLY A 56 GLN A 60 ASP A 76 PHE A 77 SER A 104 MET A 105 GLU A 121 ALA A 123 ASN A 126	SAM A 301 (-3.7A) SAM A 301 (-4.4A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-3.4A) SAM A 301 (-2.8A) None SAM A 301 (-3.1A) SAM A 301 (-4.5A) None SAM A 301 ( 3.7A) SAM A 301 (-3.0A)	0.32A	3t7sD-3kkzA: 37.8	3t7sD-3kkzA: 69.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OLM_A_198A1001_1 (ANDROGEN RECEPTOR)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	5 / 12	LEU A 189 LEU A 260 GLY A 187 LEU A 133 VAL A 180	None	1.34A	4olmA-3kkzA: undetectable	4olmA-3kkzA: 20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PGH_B_SAMB401_0 (CAFFEIC ACID O-METHYLTRANSFERASE)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	5 / 12	ASP A 52 GLY A 54 THR A 61 ASP A 76 MET A 105	None SAM A 301 (-3.7A) None SAM A 301 (-2.8A) SAM A 301 (-4.5A)	1.38A	4pghB-3kkzA: 13.1	4pghB-3kkzA: 20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWD_F_377F401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	4 / 7	GLU A 236 TYR A 249 LEU A 196 TYR A 205	None	1.12A	4twdF-3kkzA: undetectable 4twdJ-3kkzA: undetectable	4twdF-3kkzA: 21.25 4twdJ-3kkzA: 21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H2U_A_1N1A501_2 (PROTEIN-TYROSINE KINASE 6)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	3 / 3	ILE A 53 MET A 62 ASP A 76	None None SAM A 301 (-2.8A)	0.81A	5h2uA-3kkzA: undetectable	5h2uA-3kkzA: 21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C2M_B_SUEB1202_0 (NS3 PROTEASE)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	5 / 12	GLY A 29 ILE A 53 GLY A 122 SER A 149 ALA A 147	None None SAM A 301 (-4.8A) None None	1.08A	6c2mB-3kkzA: undetectable	6c2mB-3kkzA: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CDU_G_EY4G502_0 (CHIMERIC ALPHA1GABAA RECEPTOR)	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	4 / 8	ILE A 176 GLN A 179 VAL A 180 TYR A 188	None	1.04A	6cduG-3kkzA: undetectable 6cduH-3kkzA: undetectable	6cduG-3kkzA: 22.49 6cduH-3kkzA: 22.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6N7F_A_RBFA502_0 (PUTATIVE GLUTATHIONE REDUCTASE (GR))	3kkz	UNCHARACTERIZED PROTEIN Q5LES9 (Bacteroides fragilis)	4 / 7	GLY A 100 ASN A 88 GLU A 24 GLY A 59	None	0.87A	6n7fA-3kkzA: undetectable	6n7fA-3kkzA: 15.33

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1H4O_A_BEZA1162_0","PEROXIREDOXIN 5","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",5,"THR A  73;GLY A 100;LEU A 108;PHE A 110;GLY A 103","None","1.44A","1h4oA-3kkzA:undetectable;1h4oB-3kkzA:undetectable","1h4oA-3kkzA:18.70;1h4oB-3kkzA:18.70"],["2J2P_F_SC2F1291_1","FICOLIN-2;FICOLIN-2","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",4,"LEU A 108;SER A 104;ASP A 106;GLU A 135","None;SAM A 301 (-3.1A);None;None","1.22A","2j2pE-3kkzA:undetectable;2j2pF-3kkzA:undetectable","2j2pE-3kkzA:20.36;2j2pF-3kkzA:20.36"],["2KQE_A_ADNA1002_1","APRATAXIN AND PNK-LIKE FACTOR","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",4,"TYR A 249;SER A 152;CYH A 151;TYR A 247","None","1.44A","2kqeA-3kkzA:0.0","2kqeA-3kkzA:14.94"],["2Y7K_A_SALA1302_1","LYSR-TYPE REGULATORY PROTEIN","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",5,"THR A  73;ILE A 101;GLY A  74;PRO A 109;ILE A  53","None","1.36A","2y7kA-3kkzA:undetectable","2y7kA-3kkzA:24.56"],["3KKZ_A_SAMA301_0","UNCHARACTERIZED PROTEIN Q5LES9","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",12,"ARG A  25;GLN A  26;GLY A  54;GLY A  56;GLN A  60;LEU A  75;PHE A  77;LEU A  78;SER A 104;GLU A 121;ALA A 123;ASN A 126","SAM A 301 (-3.7A);SAM A 301 (-4.4A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-3.4A);None;None;SAM A 301 ( 4.1A);SAM A 301 (-3.1A);None;SAM A 301 ( 3.7A);SAM A 301 (-3.0A)","0.00A","3kkzA-3kkzA:46.9","3kkzA-3kkzA:100.00"],["3KKZ_B_SAMB302_0","UNCHARACTERIZED PROTEIN Q5LES9","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",12,"ARG A  25;GLN A  26;GLY A  27;GLY A  54;GLY A  56;GLN A  60;PHE A  77;LEU A  78;SER A 104;GLU A 121;ALA A 123;ASN A 126","SAM A 301 (-3.7A);SAM A 301 (-4.4A);SAM A 301 (-4.0A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-3.4A);None;SAM A 301 ( 4.1A);SAM A 301 (-3.1A);None;SAM A 301 ( 3.7A);SAM A 301 (-3.0A)","0.28A","3kkzB-3kkzA:43.7","3kkzB-3kkzA:100.00"],["3SXJ_A_SAMA258_0","PUTATIVE METHYLTRANSFERASE","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",11,"ARG A  25;GLN A  26;GLY A  54;GLY A  56;GLN A  60;SER A 104;MET A 105;GLU A 121;ALA A 123;TYR A 125;ASN A 126","SAM A 301 (-3.7A);SAM A 301 (-4.4A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-3.4A);SAM A 301 (-3.1A);SAM A 301 (-4.5A);None;SAM A 301 ( 3.7A);None;SAM A 301 (-3.0A)","0.29A","3sxjA-3kkzA:38.4","3sxjA-3kkzA:61.74"],["3SXJ_B_SAMB258_0","PUTATIVE METHYLTRANSFERASE","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",11,"ARG A  25;GLN A  26;GLY A  54;GLY A  56;GLN A  60;SER A 104;MET A 105;GLU A 121;ALA A 123;TYR A 125;ASN A 126","SAM A 301 (-3.7A);SAM A 301 (-4.4A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-3.4A);SAM A 301 (-3.1A);SAM A 301 (-4.5A);None;SAM A 301 ( 3.7A);None;SAM A 301 (-3.0A)","0.29A","3sxjB-3kkzA:38.4","3sxjB-3kkzA:61.74"],["3T7S_A_SAMA300_0","PUTATIVE METHYLTRANSFERASE","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",11,"ARG A  25;GLY A  54;GLY A  56;GLN A  60;ASP A  76;PHE A  77;SER A 104;MET A 105;GLU A 121;ALA A 123;ASN A 126","SAM A 301 (-3.7A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-3.4A);SAM A 301 (-2.8A);None;SAM A 301 (-3.1A);SAM A 301 (-4.5A);None;SAM A 301 ( 3.7A);SAM A 301 (-3.0A)","0.39A","3t7sA-3kkzA:39.9","3t7sA-3kkzA:69.03"],["3T7S_A_SAMA300_0","PUTATIVE METHYLTRANSFERASE","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",5,"GLN A  26;GLY A  54;GLY A  56;ASP A  76;ALA A 123","SAM A 301 (-4.4A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-2.8A);SAM A 301 ( 3.7A)","1.23A","3t7sA-3kkzA:39.9","3t7sA-3kkzA:69.03"],["3T7S_B_SAMB300_0","PUTATIVE METHYLTRANSFERASE","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",12,"ARG A  25;GLN A  26;GLY A  54;GLY A  56;GLN A  60;ASP A  76;PHE A  77;SER A 104;MET A 105;GLU A 121;ALA A 123;ASN A 126","SAM A 301 (-3.7A);SAM A 301 (-4.4A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-3.4A);SAM A 301 (-2.8A);None;SAM A 301 (-3.1A);SAM A 301 (-4.5A);None;SAM A 301 ( 3.7A);SAM A 301 (-3.0A)","0.33A","3t7sB-3kkzA:39.3","3t7sB-3kkzA:69.03"],["3T7S_C_SAMC300_0","PUTATIVE METHYLTRANSFERASE","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",10,"ARG A  25;GLY A  54;GLY A  56;GLN A  60;SER A 104;MET A 105;GLU A 121;ALA A 123;TYR A 125;ASN A 126","SAM A 301 (-3.7A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-3.4A);SAM A 301 (-3.1A);SAM A 301 (-4.5A);None;SAM A 301 ( 3.7A);None;SAM A 301 (-3.0A)","0.29A","3t7sC-3kkzA:40.0","3t7sC-3kkzA:69.03"],["3T7S_D_SAMD300_0","PUTATIVE METHYLTRANSFERASE","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",12,"ARG A  25;GLN A  26;GLY A  54;GLY A  56;GLN A  60;ASP A  76;PHE A  77;SER A 104;MET A 105;GLU A 121;ALA A 123;ASN A 126","SAM A 301 (-3.7A);SAM A 301 (-4.4A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-3.4A);SAM A 301 (-2.8A);None;SAM A 301 (-3.1A);SAM A 301 (-4.5A);None;SAM A 301 ( 3.7A);SAM A 301 (-3.0A)","0.32A","3t7sD-3kkzA:37.8","3t7sD-3kkzA:69.03"],["4OLM_A_198A1001_1","ANDROGEN RECEPTOR","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",5,"LEU A 189;LEU A 260;GLY A 187;LEU A 133;VAL A 180","None","1.34A","4olmA-3kkzA:undetectable","4olmA-3kkzA:20.66"],["4PGH_B_SAMB401_0","CAFFEIC ACID O-METHYLTRANSFERASE","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",5,"ASP A  52;GLY A  54;THR A  61;ASP A  76;MET A 105","None;SAM A 301 (-3.7A);None;SAM A 301 (-2.8A);SAM A 301 (-4.5A)","1.38A","4pghB-3kkzA:13.1","4pghB-3kkzA:20.84"],["4TWD_F_377F401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",4,"GLU A 236;TYR A 249;LEU A 196;TYR A 205","None","1.12A","4twdF-3kkzA:undetectable;4twdJ-3kkzA:undetectable","4twdF-3kkzA:21.25;4twdJ-3kkzA:21.25"],["5H2U_A_1N1A501_2","PROTEIN-TYROSINE KINASE 6","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",3,"ILE A  53;MET A  62;ASP A  76","None;None;SAM A 301 (-2.8A)","0.81A","5h2uA-3kkzA:undetectable","5h2uA-3kkzA:21.07"],["6C2M_B_SUEB1202_0","NS3 PROTEASE","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",5,"GLY A  29;ILE A  53;GLY A 122;SER A 149;ALA A 147","None;None;SAM A 301 (-4.8A);None;None","1.08A","6c2mB-3kkzA:undetectable","6c2mB-3kkzA:14.73"],["6CDU_G_EY4G502_0","CHIMERIC ALPHA1GABAA RECEPTOR","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",4,"ILE A 176;GLN A 179;VAL A 180;TYR A 188","None","1.04A","6cduG-3kkzA:undetectable;6cduH-3kkzA:undetectable","6cduG-3kkzA:22.49;6cduH-3kkzA:22.49"],["6N7F_A_RBFA502_0","PUTATIVE GLUTATHIONE REDUCTASE (GR)","3kkz","UNCHARACTERIZED PROTEIN Q5LES9","Bacteroides fragilis",4,"GLY A 100;ASN A  88;GLU A  24;GLY A  59","None","0.87A","6n7fA-3kkzA:undetectable","6n7fA-3kkzA:15.33"]]